Gabriel Bell is head of the firm’s Intellectual Property Appellate Practice and is regarded as one of the nation’s top IP appellate litigators. He represents market-leading technology and life sciences companies in the Federal Circuit and district courts. He is Chambers-ranked in IP Appellate and was recognized as the IP Appellate Litigator of the Year by LMG Life Sciences.

Gabriel combines his sophisticated technical knowledge with extensive experience in the Federal Circuit and federal district courts to guide clients across a broad range of sectors, including:

  • Computer 
  • Telecommunication
  • Pharmaceutical
  • Biotech
  • Automotive
  • Financial

He has argued over 20 Federal Circuit appeals and has led and briefed dozens of others. He also routinely argues and briefs dispositive motions in district courts. He has particular expertise in patent eligibility under Section 101 of the Patent Act.

Gabriel serves as Co-Chair of the Federal Circuit Bar Association’s Scholarship Committee and maintains an active pro bono practice, including representing veterans in appeals.

Before joining Latham, Gabriel was counsel for the US Senate Committee on the Judiciary. He has also held positions at the US Department of Justice and NASA Langley Research Center. In addition, he clerked for judges on the D.C. and Fifth Circuits.

Gabriel is admitted to practice in the Supreme Court and the Fifth, Ninth, D.C., and Federal Circuits.

Gabriel’s representative clients include:

  • Abbott
  • Avadel CNS Pharmaceuticals
  • Duolingo
  • InfoBionic
  • J&J
  • Jaguar Land Rover North America
  • Natera
  • Meta
  • Peloton

Representative appellate victories in intellectual property matters include:

  • Eolas Techs. v. Amazon.com, 2024 WL 371959 (Fed. Cir. Feb. 1, 2024)
  • Ontel Prods. v. Guy A. Shaked, 2023 WL 8723991 (Fed. Cir. Dec. 19, 2023)
  • Jazz Pharms. v. Avadel CNS, 60 F.4th 1373 (Fed. Cir. 2023)
  • Rai Strategic Holdings v. Philip Morris Prod., 2023 WL 4554551 (Fed. Cir. 2023)
  • CareDx, Inc. v. Natera, Inc., 40 F.4th 1371 (Fed. Cir. 2022) 
  • Quanergy Sys. v. Velodyne Lidar USA, 24 F.4th 1406 (Fed. Cir. 2022)
  • Flexstent, LLC v. Abbott Vascular, Inc., 2021 WL 5173377 (Fed. Cir. Nov. 8, 2021)
  • CardioNet, LLC v. InfoBionic, Inc., 2021 WL 5024388 (Fed. Cir. Oct. 29, 2021)
  • Nuance Commc’ns v. MModal, 847 F. App’x 860 (Fed. Cir. 2021)
  • CardioNet v. InfoBionic, 816 F. App’x 471 (Fed. Cir. 2020) 
  • EnerPol, LLC v. Schlumberger Tech. Corp., 809 F. App’x 795 (Fed. Cir. 2020)
  • Cheetah Omni LLC v. AT&T Servs., Inc., 949 F.3d 691 (Fed. Cir. 2020)
  • Pac. Coast Bldg. Prod., Inc. v. CertainTeed Gypsum, Inc., 816 F. App’x 454 (Fed. Cir. 2020)
  • Quest Integrity USA, LLC v. Cokebusters USA Inc., 924 F.3d 1220 (Fed. Cir. 2019)
  • In re IPR Licensing, Inc., 942 F.3d 1363 (Fed. Cir. 2019)
  • TriPlay, Inc. v. WhatsApp, Inc., 771 F. App’x 492 (Fed. Cir. 2019)
  • Intellectual Ventures I LLC v. Symantec Corp., 725 F. App’x 976 (Fed. Cir. 2018) 
  • Realtime Data, LLC v. Riverbed Tech., Inc., 742 F. App’x 505 (Fed. Cir. 2018)
  • Braemar Mfg. v. InfoBionic, Inc., 721 F. App’x 990 (Fed. Cir. 2018)   
  • Paice LLC v. Ford Motor Co., 685 F. App’x 950 (Fed. Cir. 2017)
  • Vehicle Interface Techs. v. Jaguar Land Rover, 691 F. App’x 626 (Fed. Cir. 2017)
  • Intellectual Ventures I LLC v. Symantec Corp., 838 F.3d 1307 (Fed. Cir. 2016)
  • Dynamic 3D Geosolutions LLC v. Schlumberger Limited, 837 F.3d 1280 (Fed. Cir. 2016)   
  • Jericho Systems Corp. v. Axiomatics Inc., 642 F. App’x 979 (Fed. Cir. 2016)
  • Suprema v. ITC & Cross Match Tech., 796 F.3d 1338 (Fed. Cir. 2015) (en banc)   
  • Exela Pharma Sci., LLC v. Lee and Cadence Pharm., 781 F.3d 1349 (Fed. Cir. 2015)   
  • Cadence Pharm. Inc. v. Exela Pharmsci Inc., 780 F.3d 1364 (Fed. Cir. 2015)   
  • Ultramercial v. Hulu, 772 F.3d 709 (Fed. Cir. 2014)

Bar Qualification

  • District of Columbia

Education

  • JD, Harvard Law School, 2004
    magna cum laude
  • BA in Computer Science, Yale University, 1998
    summa cum laude